Smith & Nephew plc (LON:SN)
London
· Delayed Price · Currency is GBP · Price in GBp 1,067.00
-10.50 (-0.97%)
Jun 18, 2025, 4:48 PM BST
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B USD with 4.70% growth. Smith & Nephew had revenue of $2.98B in the half year ending December 31, 2024, with 14.07% growth.
Revenue
$5.81B
Revenue Growth
+4.70%
P/S Ratio
2.01
Revenue / Employee
$334.89K
Employees
17,349
Market Cap
9.34B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
| Indivior | 905.57M |
Smith & Nephew News
- 23 hours ago - Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK - GlobeNewsWire
- 9 days ago - New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility - GlobeNewsWire
- 22 days ago - Smith+Nephew wins a DoD supply contract worth up to $75M - Seeking Alpha
- 22 days ago - Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense - GlobeNewsWire
- 6 weeks ago - Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹* - GlobeNewsWire
- 6 weeks ago - Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland - GlobeNewsWire
- 6 weeks ago - Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Smith & Nephew: Underappreciated Recovery With Strategic Upside - Seeking Alpha